Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Internship and Residency | 8 | 2019 | 319 | 1.910 |
Why?
|
| Emergency Service, Hospital | 15 | 2018 | 444 | 1.450 |
Why?
|
| Acute Coronary Syndrome | 11 | 2017 | 167 | 1.190 |
Why?
|
| Professional Competence | 2 | 2020 | 16 | 1.000 |
Why?
|
| Myocardial Infarction | 9 | 2018 | 466 | 0.920 |
Why?
|
| Chest Pain | 9 | 2018 | 205 | 0.840 |
Why?
|
| Body Surface Potential Mapping | 4 | 2012 | 10 | 0.740 |
Why?
|
| Emergency Medicine | 4 | 2019 | 110 | 0.740 |
Why?
|
| Nursing Staff | 1 | 2020 | 7 | 0.630 |
Why?
|
| Social Perception | 1 | 2020 | 22 | 0.630 |
Why?
|
| Liability, Legal | 1 | 2018 | 23 | 0.550 |
Why?
|
| Schools, Medical | 1 | 2018 | 43 | 0.550 |
Why?
|
| Curriculum | 2 | 2018 | 203 | 0.530 |
Why?
|
| Career Choice | 1 | 2016 | 43 | 0.490 |
Why?
|
| Decision Support Techniques | 4 | 2017 | 130 | 0.440 |
Why?
|
| Subcutaneous Emphysema | 1 | 2014 | 4 | 0.440 |
Why?
|
| Telemedicine | 1 | 2016 | 122 | 0.430 |
Why?
|
| Lower Extremity | 1 | 2014 | 100 | 0.400 |
Why?
|
| Critical Pathways | 4 | 2018 | 47 | 0.400 |
Why?
|
| Laparoscopy | 1 | 2014 | 184 | 0.380 |
Why?
|
| Humans | 30 | 2020 | 32282 | 0.370 |
Why?
|
| Pattern Recognition, Automated | 1 | 2012 | 36 | 0.360 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2012 | 52 | 0.360 |
Why?
|
| Myocardial Ischemia | 1 | 2012 | 98 | 0.350 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2010 | 79 | 0.340 |
Why?
|
| Risk Assessment | 4 | 2016 | 1425 | 0.330 |
Why?
|
| Emergency Treatment | 1 | 2010 | 37 | 0.310 |
Why?
|
| Postoperative Complications | 1 | 2014 | 823 | 0.300 |
Why?
|
| Algorithms | 1 | 2012 | 536 | 0.300 |
Why?
|
| Electrocardiography | 8 | 2016 | 623 | 0.290 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 853 | 0.280 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2008 | 34 | 0.270 |
Why?
|
| Female | 19 | 2020 | 19945 | 0.240 |
Why?
|
| Clinical Competence | 2 | 2018 | 330 | 0.230 |
Why?
|
| Adult | 12 | 2020 | 9259 | 0.210 |
Why?
|
| Cardiology Service, Hospital | 2 | 2015 | 19 | 0.210 |
Why?
|
| Prospective Studies | 3 | 2020 | 2316 | 0.200 |
Why?
|
| Troponin | 6 | 2016 | 101 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2013 | 1224 | 0.190 |
Why?
|
| Aged | 12 | 2018 | 10263 | 0.190 |
Why?
|
| United States | 6 | 2020 | 4072 | 0.180 |
Why?
|
| Male | 18 | 2018 | 19441 | 0.170 |
Why?
|
| Predictive Value of Tests | 6 | 2017 | 883 | 0.170 |
Why?
|
| Middle Aged | 15 | 2018 | 11851 | 0.170 |
Why?
|
| Search Engine | 1 | 2020 | 5 | 0.160 |
Why?
|
| Medical Staff, Hospital | 2 | 2011 | 19 | 0.160 |
Why?
|
| Patient Admission | 2 | 2011 | 54 | 0.160 |
Why?
|
| Public Opinion | 1 | 2020 | 17 | 0.160 |
Why?
|
| Documentation | 1 | 2019 | 39 | 0.150 |
Why?
|
| Sensitivity and Specificity | 4 | 2017 | 556 | 0.150 |
Why?
|
| Personnel Selection | 1 | 2019 | 13 | 0.150 |
Why?
|
| School Admission Criteria | 1 | 2019 | 11 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 98 | 0.140 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 95 | 0.140 |
Why?
|
| Myocardial Revascularization | 2 | 2015 | 34 | 0.140 |
Why?
|
| Coronary Angiography | 3 | 2018 | 159 | 0.130 |
Why?
|
| Exercise Test | 3 | 2016 | 217 | 0.130 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 757 | 0.130 |
Why?
|
| Troponin C | 1 | 2017 | 8 | 0.130 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 504 | 0.120 |
Why?
|
| Patient Discharge | 2 | 2015 | 204 | 0.120 |
Why?
|
| Cohort Studies | 3 | 2017 | 1840 | 0.110 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 89 | 0.110 |
Why?
|
| Perception | 1 | 2016 | 99 | 0.110 |
Why?
|
| Death | 1 | 2015 | 51 | 0.110 |
Why?
|
| Health Care Costs | 1 | 2016 | 122 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2016 | 368 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2020 | 3626 | 0.110 |
Why?
|
| Postural Balance | 1 | 2016 | 142 | 0.110 |
Why?
|
| Pesticides | 1 | 2016 | 135 | 0.110 |
Why?
|
| Decision Making | 1 | 2016 | 189 | 0.100 |
Why?
|
| Occupational Exposure | 1 | 2016 | 159 | 0.100 |
Why?
|
| Transients and Migrants | 1 | 2016 | 197 | 0.100 |
Why?
|
| North Carolina | 5 | 2016 | 1300 | 0.100 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 198 | 0.100 |
Why?
|
| Angina Pectoris | 1 | 2013 | 20 | 0.100 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 62 | 0.100 |
Why?
|
| Observer Variation | 1 | 2012 | 96 | 0.090 |
Why?
|
| Arteriovenous Malformations | 1 | 2012 | 7 | 0.090 |
Why?
|
| Single-Blind Method | 1 | 2012 | 192 | 0.090 |
Why?
|
| Neurofibromatosis 1 | 1 | 2012 | 11 | 0.090 |
Why?
|
| Cataract Extraction | 1 | 2012 | 11 | 0.090 |
Why?
|
| Carotid Artery, Common | 1 | 2012 | 48 | 0.090 |
Why?
|
| Health Expenditures | 1 | 2011 | 66 | 0.080 |
Why?
|
| Hospital Costs | 1 | 2011 | 48 | 0.080 |
Why?
|
| Hispanic Americans | 1 | 2016 | 772 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 541 | 0.080 |
Why?
|
| Inpatients | 1 | 2011 | 83 | 0.080 |
Why?
|
| Education, Medical, Graduate | 1 | 2011 | 131 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2011 | 114 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2011 | 183 | 0.080 |
Why?
|
| Delivery of Health Care | 1 | 2011 | 167 | 0.080 |
Why?
|
| Teaching | 1 | 2009 | 60 | 0.070 |
Why?
|
| Physicians | 1 | 2011 | 163 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2010 | 122 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2013 | 3900 | 0.070 |
Why?
|
| Atherectomy | 1 | 2008 | 3 | 0.070 |
Why?
|
| Ticlopidine | 1 | 2008 | 12 | 0.070 |
Why?
|
| Length of Stay | 3 | 2015 | 321 | 0.070 |
Why?
|
| Risk Factors | 4 | 2017 | 3934 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2007 | 57 | 0.070 |
Why?
|
| Hemorrhage | 1 | 2008 | 95 | 0.070 |
Why?
|
| Preoperative Care | 1 | 2008 | 125 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 395 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 312 | 0.060 |
Why?
|
| Cost Savings | 2 | 2016 | 34 | 0.050 |
Why?
|
| Time Factors | 3 | 2015 | 2205 | 0.050 |
Why?
|
| Costs and Cost Analysis | 2 | 2016 | 106 | 0.050 |
Why?
|
| Cross-Cultural Comparison | 1 | 2020 | 20 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 21 | 0.040 |
Why?
|
| Linear Models | 2 | 2011 | 425 | 0.040 |
Why?
|
| Prognosis | 2 | 2015 | 1534 | 0.040 |
Why?
|
| Contracts | 1 | 2019 | 7 | 0.040 |
Why?
|
| Correspondence as Topic | 1 | 2019 | 4 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 2240 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2019 | 113 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 907 | 0.030 |
Why?
|
| Medical History Taking | 1 | 2016 | 39 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2016 | 77 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2016 | 137 | 0.030 |
Why?
|
| Cardiology | 1 | 2016 | 104 | 0.030 |
Why?
|
| Echocardiography, Stress | 1 | 2015 | 23 | 0.030 |
Why?
|
| Survival Rate | 1 | 2016 | 893 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 854 | 0.030 |
Why?
|
| Age Factors | 1 | 2016 | 1179 | 0.020 |
Why?
|
| Observation | 1 | 2013 | 22 | 0.020 |
Why?
|
| Incidence | 1 | 2016 | 1241 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 2012 | 20 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2013 | 135 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 26 | 0.020 |
Why?
|
| Face | 1 | 2012 | 29 | 0.020 |
Why?
|
| Models, Economic | 1 | 2011 | 18 | 0.020 |
Why?
|
| Faculty | 1 | 2011 | 14 | 0.020 |
Why?
|
| Drug Costs | 1 | 2011 | 46 | 0.020 |
Why?
|
| Adenosine | 1 | 2011 | 68 | 0.020 |
Why?
|
| Dobutamine | 1 | 2011 | 54 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 773 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 120 | 0.020 |
Why?
|
| Echocardiography | 1 | 2011 | 190 | 0.020 |
Why?
|
| Myocardium | 1 | 2011 | 184 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 253 | 0.020 |
Why?
|
| Heart | 1 | 2011 | 177 | 0.020 |
Why?
|
| Internet | 1 | 2011 | 202 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 38 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 477 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2009 | 565 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2010 | 183 | 0.020 |
Why?
|
| Hospitalization | 1 | 2010 | 475 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2009 | 1479 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2010 | 3416 | 0.010 |
Why?
|